Cell
Volume 184, Issue 7, 1 April 2021, Pages 1671-1692
Journal home page for Cell

Review
COVID-19 and the human innate immune system

https://doi.org/10.1016/j.cell.2021.02.029Get rights and content
Under an Elsevier user license
open archive

Summary

The introduction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the human population represents a tremendous medical and economic crisis. Innate immunity—as the first line of defense of our immune system—plays a central role in combating this novel virus. Here, we provide a conceptual framework for the interaction of the human innate immune system with SARS-CoV-2 to link the clinical observations with experimental findings that have been made during the first year of the pandemic. We review evidence that variability in innate immune system components among humans is a main contributor to the heterogeneous disease courses observed for coronavirus disease 2019 (COVID-19), the disease spectrum induced by SARS-CoV-2. A better understanding of the pathophysiological mechanisms observed for cells and soluble mediators involved in innate immunity is a prerequisite for the development of diagnostic markers and therapeutic strategies targeting COVID-19. However, this will also require additional studies addressing causality of events, which so far are lagging behind.

Keywords

COVID-19
SARS-CoV-2
pandemic
innate immunity
interferon
viral sepsis
immunosuppressive cells
monocytes
granulocytes
genetics
trained immunity

Cited by (0)